glp-1 drugs market dynamics 2025 Agonists Weight Loss Report, 2025-2030 Novo cuts GLP-1 prices 70%,
Description
New Formulations: Efforts are underway to create more convenient formulations, including longer-acting injectables that may only require monthly administration and improved oral versions
5 Fu, Z., Gong, L., Liu, J., Wu, J., Barrett, E
Health Syst
Still today, individuals with diabetes have an approximately two-fold increased risk of all-cause mortality than those without diabetes [3]
2.Hales C, Carroll M, Fryar CD, et al
Similar trends were observed for systolic blood pressure, although the authors note that these analyses were exploratory and based on limited, inconsistently reported data
